Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH
BEIJING,SHANGHAI and BOSTON,Dec. 9,2024-- Jacobio Pharma (1167.HK),a clinical-stage oncology company dedicated to developing therapies toward undruggable targets,today presented preliminary Phase I da